AI-ECG Tracker vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-ECG Tracker

by Carewell Health

VX1+

by Volta Medical

AI Verdict

Tool A, AI-ECG Tracker, is designed for the AI-powered auto-diagnosis of various cardiac abnormalities from standard 12-lead ECGs, serving general cardiology and emergency medicine. In contrast, Tool B, VX1+, offers real-time AI assistance to electrophysiologists during cardiac ablation procedures for atrial fibrillation and atrial tachycardia, analyzing electrograms from specialized EP systems. While both are cardiology AI tools, Tool A focuses on diagnostic interpretation, whereas Tool B provides interventional procedural support in a highly specialized setting.

Choose AI-ECG Tracker if…

Choose the AI-ECG Tracker if your primary need is rapid, highly accurate AI-powered auto-diagnosis of standard 12-lead ECGs for a broad spectrum of common cardiac abnormalities. This tool is ideal for emergency departments or general cardiology clinics requiring quick interpretation and comprehensive classification of conditions like arrhythmias, myocardial ischemia, and infarction.

View AI-ECG Tracker →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist seeking real-time, AI-driven assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to integrate with existing EP systems to identify abnormal electrograms, providing critical insights to guide precise ablation targets during live procedures.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-ECG Tracker	VX1+
Deployment	Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.	Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1+

Tool B emphasizes a 'simple user interface with color coding' and real-time assistance, which is crucial for immediate clarity and ease of use in a demanding interventional setting. While Tool A offers a comprehensive diagnostic client, Tool B's focus on streamlined, real-time procedural support gives it an edge in usability for its specific application.

Clinical Value

VX1+

Both tools are FDA cleared and offer significant clinical value. However, Tool B provides real-time, AI-driven insights directly assisting electrophysiologists during complex cardiac ablation procedures, which can have a more immediate and direct impact on procedural success and patient outcomes in a highly specialized, interventional setting. Tool A offers broad and accurate ECG diagnostic support, which is valuable but less directly interventional.

Pricing & Value

Tie

Neither Tool A nor Tool B provides publicly available pricing information. Without any details on cost, it is impossible to conduct a meaningful comparison of their relative value or cost-effectiveness.

Enterprise Readiness

AI-ECG Tracker

Tool A explicitly mentions a 'Web-based Management Portal for organization settings, security, and task management' and an optional cloud service, indicating a more comprehensive suite of features for enterprise deployment and administration. Its distribution to over 100 countries also suggests robust operational capabilities for large-scale adoption. Tool B focuses on integration with existing EP systems but lacks explicit broader enterprise management features.

Innovation

VX1+

While Tool A is a pioneer in AI for ECG auto-diagnosis, Tool B applies AI in a more novel and challenging real-time interventional context during cardiac ablation procedures. Providing AI-driven insights to guide electrophysiologists during live, complex procedures represents a significant advancement in procedural assistance and decision-making.

Support & Docs

Tie

The provided structured facts do not contain any specific information regarding the availability, quality, or scope of support services or documentation for either Tool A or Tool B. Therefore, it is not possible to differentiate between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-ECG Tracker	VX1+
Company	Shenzhen Carewell Electronics Co. (subsidiary of Lepu Medical)	Volta Medical
Tagline	Forever Innovation Forever Care!	Transforming EP Data into AI Solutions
Primary Function	AI-powered ECG auto-analysis and diagnosis	AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia
Key Specialties	Cardiology, Emergency Medicine	Cardiology

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Tracker and VX1+.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose of each AI tool?

The AI-ECG Tracker is designed for AI-powered auto-analysis and diagnosis of 12-lead ECG data, identifying common cardiac abnormalities such as arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. VX1+ assists electrophysiologists in real-time identification of abnormal electrograms, specifically spatio-temporal dispersed electrograms (DEs), during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.

How do these tools integrate into existing clinical workflows and IT infrastructure?

The AI-ECG Tracker is deployed on-premise with an AI-ECG Workstation and Diagnostic Client, offering an optional cloud service for remote diagnostic services. VX1+ is a software application that integrates with existing EP recording and 3D mapping systems, including those from Boston Scientific, GE HealthCare, and Abbott.

Which specific cardiac conditions or procedures does each AI tool target?

The AI-ECG Tracker provides comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications, including various arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. VX1+ specifically targets the identification of dispersed electrograms (DEs) during atrial fibrillation and atrial tachycardia ablation procedures.

Does either tool provide real-time guidance during a procedure, or are they primarily for post-acquisition analysis?

VX1+ provides real-time manual or automatic annotation of 3D anatomical and electrical maps, offering AI-driven insights to assist electrophysiologists *during* ablation procedures. The AI-ECG Tracker focuses on rapid diagnosis of ECG data in approximately 3 seconds, which is a post-acquisition analysis, though very fast.

What are the key performance indicators or accuracy claims for each tool?

The AI-ECG Tracker boasts high accuracy (over 95%) for common cardiac abnormalities. VX1+ assists in the identification of dispersed electrograms and provides cycle length estimation, with a booster mode for increased sensitivity during AT or slow AF, though specific accuracy percentages are not stated.

What are the data input requirements and compatibility with existing medical devices for each tool?

The AI-ECG Tracker supports 12-lead ECG data collection. VX1+ is compatible with existing 510(k)-cleared catheters and specific data acquisition systems, including Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.